Royal Philips’ $646M Deal: US Govt Uses Defense Production Act To Order 45,500 Ventilators

Five other ventilator manufacturers will also get contracts within the “coming week,” Department of Health and Human Services says

Philips will make 43,000 medical ventilators by the end of 2020 for use in the US and manufacture 2,500 more for the Strategic National Stockpile in a contract worth more than half a billion dollars.

Amsterdam, Netherlands-march 13, 2016: Royal Philips is a Dutch electronics company.

Royal Philips NV will manufacture 43,000 medical ventilators by the end of the year and make 2,500 more for the Strategic National Stockpile in a deal with the US government worth $646.7m.

Philips contracted with the Department of Health and Human Services (HHS) for the ventilators under the Defense Production Act. The massive order, announced on 8 April, comes less than a...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Medtech Insight

BD To Shift China-Facing Production, Ramp Up US Output With $2.5B To Counter Tariff Blow

 
• By 

BD is accelerating transitions of product sourcing for China to avoid tariffs. Historically, products like Vacutainer were exported from Sumter, SC, to China, and Flush was shipped from Columbus, NE.

Zika Virus Test Among 4 New FDA Device Classifications

 
• By 

The FDA plans to announce class II status for four new device types, including tests for the Zika virus and genetic condition Fragile X. This follows earlier announcements and highlights a trend toward diagnostic classifications. The classifications are considered deregulatory, meaning they will hel

FDA Draft Guidance Introduces Electric Submission For Q-Sub Process

 

The US FDA says its updated draft guidance represents one of several steps the agency is taking to develop electronic submission templates for the medical device industry. The document introduces stakeholders to currently available resources for supporting their pre-subs to the agency.